Time to and predictors of CD4+ T-lymphocytes recovery in HIV-infected children initiating highly active antiretroviral therapy in Ghana

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Renner, Lorna ^a   Prin, Meghan ^b   Li, Fang Yong ^c   Goka, Bamenla ^a   Northrup, Veronika ^c   Paintsil, Elijah ^c  

^a UNIVERSITY OF GHANA   (Ghana)

^b University of Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873173023     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/896040     Document Type: Article

References (38)

1. Schnittman S. M., Lane H. C., Greenhouse J., Justement J. S., Baseler M., Fauci A. S., Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proceedings of the National Academy of Sciences of the United States of America 1990 87 16 6058 6062 2-s2.0-0025160079 10.1073/pnas.87.16.6058 (Pubitemid 20258955)
2. Veazey R. S., DeMaria M., Chalifoux L. V., Shvetz D. E., Pauley D. R., Knight H. L., Rosenzweig M., Johnson R. P., Desrosiers R. C., Lackner A. A., Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998 280 5362 427 431 2-s2.0-0032540418 10.1126/science.280.5362.427 (Pubitemid 28208163)
3. Vlahov D., Graham N., Hoover D., Flynn C., Bartlett J. G., Margolick J. B., Lyles C. M., Nelson K. E., Smith D., Holmberg S., Farzadegan H., Prognostic indicators for AIDS and infectious disease death in HIV- infected injection drug users: plasma viral load and CD4+ cell count. Journal of the American Medical Association 1998 279 1 35 40 2-s2.0-0010240431 10.1001/jama.279.1.35 (Pubitemid 28070548)
4. Nishanian P., Taylor J. M. G., Manna B., Aziz N., Grosser S., Giorgi J. V., Detels R., Fahey J. L., Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 18 2 162 170 2-s2.0-0032104043
5. Pantaleo G., Graziosi C., Fauci A. S., Mechanisms of disease: the immunopathogenesis of human immunodeficiency virus infection. The New England Journal of Medicine 1993 328 5 327 335 2-s2.0-0027908330 10.1056/ NEJM199302043280508 (Pubitemid 23035333)
6. Mellors J. W., Muñoz A., Giorgi J. V., Margolick J. B., Tassoni C. J., Gupta P., Kingsley L. A., Todd J. A., Saah A. J., Detels R., Phair J. P., Rinaldo C. R., Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of Internal Medicine 1997 126 12 946 954 2-s2.0-1842296349 (Pubitemid 27255797)
7. Diagbouga S., Chazallon C., Kazatchkine M. D., Van De Perre P., Inwoley A., M'Boup S., David M. P., Ténin A. T., Soudré R., Aboulker J. P., Weiss L., Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 2003 17 15 2201 2208 2-s2.0-10744228347 10.1097/00002030-200310170-00008 (Pubitemid 37338893)
8. Mandy F., Janossy G., Bergeron M., Pilon R., Faucher S., Affordable CD4+ T-cell enumeration for resource-limited regions: a status report for 2008. Cytometry B 2008 74 supplement 1 S27 S39 2-s2.0-42449163377 10.1002/cyto.b.20414 (Pubitemid 351569270)
9. Taiwo B. O., Murphy R. L., Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa. Cytometry B 2008 74 supplement 1 S11 S18 2-s2.0-42449125184 10.1002/cyto.b.20383 (Pubitemid 351569268)
10. Katzenstein D., Laga M., Moatti J. P., The evaluation of the HIV/AIDS drug access initiatives in Côte D'ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa. AIDS 2003 17 supplement 3 S1 S4 2-s2.0-0043130208 (Pubitemid 36951663)
11. Song R., Jelagat J., Dzombo D., Mwalimu M., Mandaliya K., Shikely K., Essajee S., Efficacy of highly active antiretroviral therapy in HIV-1-infected children in Kenya. Pediatrics 2007 120 4 e856 e861 2-s2.0-35148813458 10.1542/peds.2006-1122 (Pubitemid 47549528)
12. Reddi A., Leeper S. C., Grobler A. C., Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics 2007 7 13
13. Puthanakit T., Oberdorfer A., Akarathum N., Kanjanavanit S., Wannarit P., Sirisanthana T., Sirisanthana V., Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clinical Infectious Diseases 2005 41 1 100 107 2-s2.0-20844446474 10.1086/430714 (Pubitemid 40863751)
14. Puthanakit T., Kerr S. J., Ananworanich J., Bunupuradah T., Boonrak P., Sirisanthana V., Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatric Infectious Disease Journal 2009 28 6 488 492 2-s2.0-67649559583 10.1097/INF.0b013e318194eea6
15. Kumarasamy N., Venkatesh K. K., Devaleenol B., Poongulali S., Moothi S. N., Solomon S., Safety, tolerability and effectiveness of generic HAART in HIV-Infected children in South India. Journal of Tropical Pediatrics 2009 55 3 155 159 2-s2.0-67149125836 10.1093/tropej/fmn080
16. Janssens B., Raleigh B., Soeung S., Akaob K., Te V., Gupta J., Vun M. C., Ford N., Nouhinf J., Nerrienet E., Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007 120 5 e1134 e1140 2-s2.0-36048946593 10.1542/peds.2006-3503 (Pubitemid 350085507)
17. George E., Noël F., Bois G., Cassagnol R., Estavien L., De Rouzier P. M., Verdier R. I., Johnson W. D., Pape J. W., Fitzgerald D. W., Wright P. F., Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases 2007 195 10 1411 1418 2-s2.0-34248165490 10.1086/514823 (Pubitemid 46717458)
18. Bolton-Moore C., Mubiana-Mbewe M., Cantrell R. A., Chintu N., Stringer E. M., Chi B. H., Sinkala M., Kankasa C., Wilson C. M., Wilfert C. M., Mwango A., Levy J., Abrams E. J., Bulterys M., Stringer J. S. A., Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. Journal of the American Medical Association 2007 298 16 1888 1899 2-s2.0-35448950466 10.1001/jama.298.16.1888 (Pubitemid 350005233)
19. Paintsil E., Ghebremichael M., Romano S., Andiman W. A., Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression. Pediatric Infectious Disease Journal 2008 27 7 629 635 2-s2.0-50949126367 10.1097/INF.0b013e3181693892
20. Wade A. M., Ades A. E., Incorporating correlations between measurements into the estimation of age-related reference ranges. Statistics in Medicine 1998 17 17 1989 2002 2-s2.0-0031671318 10.1002/(SICI)1097-0258(19980915)17:171989:: AID-SIM891>3.0.CO;2-Q (Pubitemid 28425262)
21. Stein D. S., Korvick J. A., Vermund S. H., CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. Journal of Infectious Diseases 1992 165 2 352 363 2-s2.0-0026515551
22. Kline M. W., Rugina S., Ilie M., Matusa R. F., Schweitzer A. M., Calles N. R., Schwarzwald H. L., Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy. Pediatrics 2007 119 5 e1116 e1120 2-s2.0-34248191264 10.1542/peds.2006-2802 (Pubitemid 46715649)
23. O'Brien D. P., Sauvageot D., Olson D., Schaeffer M., Humblet P., Pudjades M., Ellman T., Zachariah R., Szumilin E., Arnould L., Read T., Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clinical Infectious Diseases 2007 44 9 1245 1248 2-s2.0-34247275856 10.1086/513433 (Pubitemid 46651252)
24. Soh C. H., Oleske J. M., Brady M. T., Spector S. A., Borkowsky W., Burchett S. K., Foca M. D., Handelsman E., Jiménez E., Dankner W. M., Hughes M. D., Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003 362 9401 2045 2051 2-s2.0-9144258622 10.1016/S0140-6736(03)15098-2 (Pubitemid 38032756)
25. Moore R. D., Keruly J. C., CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Diseases 2007 44 3 441 446 2-s2.0-33846439783 10.1086/510746 (Pubitemid 46147630)
26. Sutcliffe C. G., van Dijk J. H., Bolton C., Persaud D., Moss W. J., Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. The Lancet Infectious Diseases 2008 8 8 477 489 2-s2.0-47549096477 10.1016/S1473-3099(08)70180-4 (Pubitemid 352005822)
27. Walker A. S., Doerholt K., Sharland M., Gibb D. M., Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS 2004 18 14 1915 1924 2-s2.0-4744365211 10.1097/00002030-200409240-00007 (Pubitemid 39313207)
28. Kamya M. R., Mayanja-Kizza H., Kambugu A., Bakeera-Kitaka S., Semitala F., Mwebaze-Songa P., Castelnuovo B., Schaefer P., Spacek L. A., Gasasira A. F., Katabira E., Colebunders R., Quinn T. C., Ronald A., Thomas D. L., Kekitiinwa A., Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2007 46 2 187 193 2-s2.0-34748846895 10.1097/QAI.0b013e31814278c0 (Pubitemid 47482614)
29. Nicastri E., Angeletti C., Palmisano L., Sarmati L., Chiesi A., Geraci A., Andreoni M., Vella S., Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005 19 6 577 583 2-s2.0-17444427676 (Pubitemid 40543980)
30. Moore A. L., Mocroft A., Madge S., Devereux H., Wilson D., Phillips A. N., Johnson M., Gender differences in virologic response to treatment in an HIV-positive population: a cohort study. Journal of Acquired Immune Deficiency Syndromes 2001 26 2 159 163 2-s2.0-0035251403 (Pubitemid 32224187)
31. Notermans D. W., Pakker N. G., Hamann D., Foudraine N. A., Kauffmann R. H., Meenhorst P. L., Goudsmit J., Roos M. T. L., Schellekens P. T. A., Miedema F., Danner S. A., Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. Journal of Infectious Diseases 1999 180 4 1050 1056 2-s2.0-0033394585 10.1086/315013 (Pubitemid 30070186)
32. Staszewski S., Miller V., Sabin C., Schlecht C., Gute P., Stamm S., Leder T., Berger A., Weidemann E., Hill A., Phillips A., Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS 1999 13 8 951 956 2-s2.0-0032968454 10.1097/00002030-199905280-00011 (Pubitemid 29240190)
33. García F., De Lazzari E., Plana M., Castro P., Mestre G., Nomdedeu M., Fumero E., Martínez E., Mallolas J., Blanco J. L., Miró J. M., Pumarola T., Gallart T., Gatell J. M., Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. Journal of Acquired Immune Deficiency Syndromes 2004 36 2 702 713 2-s2.0-2542496096 10.1097/00126334-200406010-00007 (Pubitemid 38685964)
34. Brogly S., Williams P., Seage G. R. III, Oleske J. M., Van Dyke R., McIntosh K., Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. Journal of the American Medical Association 2005 293 18 2213 2220 2-s2.0-18244408516 10.1001/jama.293.18.2213 (Pubitemid 40629187)
35. Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A., Emini E. A., Chodakewitz J. A., Deutsch P., Holder D., Schleif W. A., Condra J. H., Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. The New England Journal of Medicine 1997 337 11 734 739 2-s2.0-0030869269 10.1056/NEJM199709113371102 (Pubitemid 27417972)
36. Hammer S. M., Saag M. S., Schechter M., Montaner J. S. G., Schooley R. T., Jacobsen D. M., Thompson M. A., Carpenter C. C. J., Fischl M. A., Gazzard B. G., Hirsch M. S., Katzenstein D. A., Richman D. D., Vella S., Yeni P. G., Volberding P. A., Treatment for adult HIV infection: 2006 Recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association 2006 296 7 827 843 2-s2.0-33747122666 10.1001/jama.296.7.827 (Pubitemid 44223106)
37. O'Brien W. A., Hartigan P. M., Daar E. S., Simberkoff M. S., Hamilton J. D., Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Annals of Internal Medicine 1997 126 12 939 945 (Pubitemid 27255796)
38. Kaufmann G. R., Furrer H., Ledergerber B., Perrin L., Opravil M., Vernazza P., Cavassini M., Bernasconi E., Rickenbach M., Battegay M., Characteristics, determinants, and clinical relevance of CD4+ T cell recovery to 500 cells/ μ L in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases 2005 41 3 361 372 2-s2.0-22544453346 10.1086/431484 (Pubitemid 41022115)